ACE and chronic kidney disease: The RAAS plays a key role in the pathogenesis of CKD, where, particularly, Ang (angiotensin) II acts as a central mediator.84,85 Therefore, inhibition of the RAAS by either ACE (angiotensin-converting enzyme) inhibitors or angiotensin receptor blockers (ARBs) has been demonstrated to be an effective treatment approach.